ATHE

Alterity Therapeutics
ATHE

Overview Fund Activity

10 hedge funds and large institutions have $361K invested in Alterity Therapeutics in 2019 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 0 closing their positions.

Holders
10
Holders Change
+2
Holders Change %
+25%
% of All Funds
0.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
2
Reduced
3
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
OMC
1
Old Mission Capital
Illinois
$17K
2
Geode Capital Management
2
Geode Capital Management
Massachusetts
$16K
3
Morgan Stanley
3
Morgan Stanley
New York
$299K
4
UBS Group
4
UBS Group
Switzerland
$8K
5
Wells Fargo
5
Wells Fargo
California
$1K

Top Sellers

1
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$15K
2
AIM
2
Advantage Investment Management
Iowa
$1K
3
AG
3
Advisor Group
Arizona
$3K
Name Market Value Shares Shares
Change 		Shares
Change %
Morgan Stanley
1
Morgan Stanley
New York
$299K 228,200 +9,390 +4%
OMC
2
Old Mission Capital
Illinois
$17K 12,707 +12,707 New
Geode Capital Management
3
Geode Capital Management
Massachusetts
$16K 12,128 +12,128 New
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$15K 11,451 -29,704 -72%
UBS Group
5
UBS Group
Switzerland
$8K 6,339 +4,269 +206%
AG
6
Advisor Group
Arizona
$3K 2,500 -12 -0.5%
AIM
7
Advantage Investment Management
Iowa
$1K 1,065 -50 -4%
NFG
8
Next Financial Group
Texas
$1K 583 – –
Wells Fargo
9
Wells Fargo
California
$1K 500 +500 New
APA
10
American Portfolios Advisors
New York
$109 83 – –
CFGS
11
Concourse Financial Group Securities
Alabama
– – – –